The Gut and Parkinson’s Disease: Hype or Hope?

por Scheperjans, Filip, Derkinderen, Pascal, Borghammer, Per
Publicado 2018

Deep brain stimulation for dystonia in Finland during 2007–2016

por Ortiz, Rebekka M., Scheperjans, Filip, Pekkonen, Eero
Publicado 2019

The prevalence of adult-onset isolated dystonia in Finland 2007-2016

por Ortiz, Rebekka, Scheperjans, Filip, Mertsalmi, Tuomas, Pekkonen, Eero
Publicado 2018

Irritable Bowel Syndrome and Risk of Parkinson’s Disease in Finland: A Nationwide Registry-Based Cohort Study

por Mertsalmi, Tuomas H., But, Anna, Pekkonen, Eero, Scheperjans, Filip
Publicado 2021

Comorbidity and retirement in cervical dystonia

por Ortiz, Rebekka M., Scheperjans, Filip, Mertsalmi, Tuomas, Pekkonen, Eero
Publicado 2019

Hypoperfusion of an Entire Cerebral Hemisphere – Stroke or Postictal Deficit?

por Scheperjans, Filip, Silvennoinen, Heli, Mustanoja, Satu, Palomäki, Maarit, Forss, Nina
Publicado 2011

Gut bacterial tyrosine decarboxylase associates with clinical variables in a longitudinal cohort study of Parkinsons disease

por van Kessel, Sebastiaan P., Auvinen, Petri, Scheperjans, Filip, El Aidy, Sahar
Publicado 2021

Motor outcome and electrode location in deep brain stimulation in Parkinson's disease

por Koivu, Maija, Huotarinen, Antti, Scheperjans, Filip, Laakso, Aki, Kivisaari, Riku, Pekkonen, Eero
Publicado 2018

Increasing Comparability and Utility of Gut Microbiome Studies in Parkinson’s Disease: A Systematic Review

por Boertien, Jeffrey M., Pereira, Pedro A.B., Aho, Velma T.E., Scheperjans, Filip
Publicado 2019

Gut microbiota composition is associated with narcolepsy type 1

por Lecomte, Alexandre, Barateau, Lucie, Pereira, Pedro, Paulin, Lars, Auvinen, Petri, Scheperjans, Filip, Dauvilliers, Yves
Publicado 2020

IV Thrombolysis-Bridging and Endovascular Treatment for Occlusive Internal Carotid Artery Dissection with Tandem Occlusion

por Scheperjans, Filip, Pekkola, Johanna, Mustanoja, Satu, Putaala, Jukka, Tiainen, Marjaana, Ollila, Leena, Paananen, Tapio, Lappalainen, Kimmo
Publicado 2012

Real-Life Experience on Directional Deep Brain Stimulation in Patients with Advanced Parkinson’s Disease

por Koivu, Maija, Scheperjans, Filip, Eerola-Rautio, Johanna, Vartiainen, Nuutti, Resendiz-Nieves, Julio, Kivisaari, Riku, Pekkonen, Eero
Publicado 2022

Gut microbiome alpha-diversity is not a marker of Parkinson’s disease and multiple sclerosis

por Plassais, Jonathan, Gbikpi-Benissan, Guillaume, Figarol, Marine, Scheperjans, Filip, Gorochov, Guy, Derkinderen, Pascal, Cervino, Alessandra C L
Publicado 2021

Gut microbiota in Parkinson's disease: Temporal stability and relations to disease progression

por Aho, Velma T.E., Pereira, Pedro A.B., Voutilainen, Sari, Paulin, Lars, Pekkonen, Eero, Auvinen, Petri, Scheperjans, Filip
Publicado 2019

Multiomics implicate gut microbiota in altered lipid and energy metabolism in Parkinson’s disease

por Pereira, Pedro A. B., Trivedi, Drupad K., Silverman, Justin, Duru, Ilhan Cem, Paulin, Lars, Auvinen, Petri, Scheperjans, Filip
Publicado 2022

Individual parkinsonian motor signs and striatal dopamine transporter deficiency: a study with [I-123]FP-CIT SPECT

por Mäkinen, Elina, Joutsa, Juho, Jaakkola, Elina, Noponen, Tommi, Johansson, Jarkko, Pitkonen, Miia, Levo, Reeta, Mertsalmi, Tuomas, Scheperjans, Filip, Kaasinen, Valtteri
Publicado 2019

Feasibility and patient acceptability of a commercially available wearable and a smart phone application in identification of motor states in parkinson’s disease

por Liikkanen, Sammeli, Sinkkonen, Janne, Suorsa, Joni, Kaasinen, Valtteri, Pekkonen, Eero, Kärppä, Mikko, Scheperjans, Filip, Huttunen, Teppo, Sarapohja, Toni, Pesonen, Ullamari, Kuoppamäki, Mikko, Keränen, Tapani
Publicado 2023

Floating door sign does not differentiate Parkinson’s disease from essential tremor

por Räty, Valtteri, Eklund, Mikael, Nuuttila, Simo, Jaakkola, Elina, Mäkinen, Elina, Murtomäki, Kirsi, Nojonen, Tanja, Levo, Reeta, Mertsalmi, Tuomas, Joutsa, Juho, Scheperjans, Filip, Kaasinen, Valtteri
Publicado 2023

Relationships of gut microbiota, short-chain fatty acids, inflammation, and the gut barrier in Parkinson’s disease

por Aho, Velma T. E., Houser, Madelyn C., Pereira, Pedro A. B., Chang, Jianjun, Rudi, Knut, Paulin, Lars, Hertzberg, Vicki, Auvinen, Petri, Tansey, Malú G., Scheperjans, Filip
Publicado 2021

Dopamine transporter binding in the brain is linked to irritable bowel syndrome in Parkinson's disease

por Murtomäki, Kirsi, Joutsa, Juho, Mertsalmi, Tuomas, Jaakkola, Elina, Mäkinen, Elina, Levo, Reeta, Eklund, Mikael, Nuuttila, Simo, Pekkonen, Eero, Noponen, Tommi, Ihalainen, Toni, Kaasinen, Valtteri, Scheperjans, Filip
Publicado 2023